EUCTR2007-003080-45-GB进行中（未招募）1 期
Phase ll study evaluating the toxicity and efficacy of a modified German Paediatric Hodgkin's Lymphoma protocol (HD95) in young adults (aged 18-30 years) with Hodgkin's Lymphoma - 18-30 Study
niversity College London0 个研究点目标入组 0 人开始时间: 2007年9月3日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •1) Biopsy proven de novo calssical Hodgkin's lymphoma
- •2) No previous chemotherapy or radiotherapy
- •3) Age 18-30 years
- •4) Any stage
- •5) Able to give informed consent
- •6) Agreement to take adequate precautions to prevent conception during chemo-/radiotherapy and for up to one year afterwards
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1) Nodular Lymphocyte Predominant Hodgkin's disease
- •2) Previous chemotherapy or radiotherapy
- •3) Known or suspected HIV infection
- •4) Pre-existing neurological disorder
- •5) Serious co-morbidity which may prevent administration of study treatment
研究者
相似试验
招募中
2 期
To evaluate the impact of PET scan based radiotherapy planning for cervical cancer in Indian women.CTRI/2016/05/006924Department of Biotechnology Government of India60
进行中（未招募）
不适用
Phase II study evaluating the toxicity and activity of the combination lapatinib + capecitabine in elderly patients aged 70 and over with metastatic breast cancer over expressing HER2ocally advanced or metastatic breast cancer over expressing HER2 and = 70 years oldMedDRA version: 12.0Level: LLTClassification code 10055113Term: Breast cancer metastaticMedDRA version: 12.0Level: LLTClassification code 10048406Term: Breast cancer aggravatedEUCTR2009-015981-73-FRFNCLCC (Fédération Nationale des Centres de Lutte Contre le Cancer)
尚未招募
2 期
To study the efficacy of a ayurvedic polyherbal preparation (Carctol-S) in patients with recurrent ovarian cancer.CTRI/2019/02/017873Central Council for Research in Ayurvedic Sciences Ministry of AYUSH Government of India
进行中（未招募）
不适用
A Phase II Study to evaluate activity and toxicity of Gemcitabine in Combination with Pemetrexed long term infusion in the Treatment of pretreated Metastatic Colorectal Cancer PatientsPretreated patients with advanced colorectal cancerMedDRA version: 14.1Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-019841-25-ITISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI
招募中
2 期
Phase II study evaluating the efficacy and safety of the Bevacizumab / Docetaxel maintenance therapy beyond stable disease in patients with advanced relapsed non-squamous NSCLC who received Bevacizumab / pemetrexed / platinum induction therapyJPRN-UMIN000010055Respiratory Center, Showa University Northern Yokohama Hospital20